Pattern
Austin, US · Founded 2016 · 76 employees on LinkedIn · 2 known investors
Find your way into Pattern
Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps. Its phenotypic testing targets common infection sites to support faster, more focused antibiotic treatment in hospitals and combat antibiotic resistance.
Founders & leadership
Pattern was founded in 2016 by Nick Arab and Ross Johnson.
NA
Nick ArabFounder & CTO
RJ
Ross JohnsoninCo-founder & Chief Engineer
CB
TD
Travis DaviesSVP, Operations
KF
Kyle FielekeSVP, Corporate Development & Finance
DB
David BussianSVP, Clinical, Regulatory & Assay Development
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AAug 2020Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlap
Fortis Life Sciences18 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Talus Bio13 shared keywordsTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
Companies competing with Pattern for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Pattern do?
- Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps. Its phenotypic testing targets common infection sites to support faster, more focused antibiotic treatment in hospitals and combat antibiotic resistance.
- Who founded Pattern?
- Pattern was founded by Nick Arab, Ross Johnson in 2016.
- Who are Pattern's investors?
- Pattern's investors include AMR Action Fund, Illumina Ventures.
- Where is Pattern headquartered?
- Pattern is headquartered in Austin, US.